Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300070216Phase 4Not yet recruiting
Phase 4, randomised trial of bupivacaine in postoperative pain (4 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Total Sufentanil Dosage 48 hours after surgery. Planned start Apr 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300070216.